Deferoxamine Infusion Test

From Anvita Health Wiki

Contents 1 Indications 2 Procedure 3 More General Terms 4 Additional Terms 5 References

Indications

• alumininum toxicity, serum aluminum > 60 ng/mL (prior to dialysis)

Procedure

• infusion of 5 mg/kg of desferoxamine IV over 20 minutes or more post dialysis
• an increase in serum aluminum > 150 ng/mL with sample prior to next dialysis session

More General Terms

• clinical procedure

Additional Terms

• aluminum toxicity
• deferoxamine (Desferal)

References

1. Milliner DS et al Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy. Ann Intern Med. 1984 Dec;101(6):775-9. PMID: [1]
2. DESFERAL: Novartis Pharmaceuticals [2]

deferoxamine infusion test